Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 334 (2-3) , 273-279
- https://doi.org/10.1016/s0014-2999(97)01152-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1Neurology, 1997
- A rapid and reversible change in dopamine transporters induced by methamphetamineEuropean Journal of Pharmacology, 1997
- A simple synthesis of [11C]Dihydrotetrabenazine (DTBZ)Nuclear Medicine and Biology, 1997
- Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecificEuropean Journal of Pharmacology, 1995
- Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigraNeuroscience Letters, 1994
- Neurotransmitter Transporters: Recent ProgressAnnual Review of Neuroscience, 1993
- Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamineBrain Research, 1992
- Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserinNeuroscience, 1989
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine AdministrationScience, 1978